Surgical Hemostats Market Size Forecast: Revenue and CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Surgical Hemostats Industry In 2025?

The surgical hemostats market has demonstrated robust expansion over recent years. It is anticipated to grow from $3.68 billion in 2024 to $3.93 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.9%. The historical progression of this market can be attributed to an increase in surgical procedures, a higher incidence of trauma and accidents, an expanding geriatric population, the rising adoption of minimally invasive surgeries, and an increasing prevalence of chronic diseases.

The surgical hemostats market size is anticipated to demonstrate significant expansion in the upcoming period. This market is set to reach $5.09 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.6%. Factors contributing to this growth during the forecast timeframe include a heightened need for sophisticated wound closure solutions, an increase in ambulatory surgical facilities, a greater inclination towards biodegradable hemostatic agents, an expanding application of combination hemostatic products, and a growing occurrence of lifestyle-related ailments necessitating surgical intervention. Key trends for the forecast period encompass technological progress in absorbable hemostatic materials, the incorporation of technology into robotic surgical procedures, the creation of advanced hemostatic formulations, synergy with intelligent surgical instruments, and novel developments in hemostatics derived from plants.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25916&type=smp

What Are The Drivers Pushing New Developments In The Surgical Hemostats Market?

The expanding occurrence of trauma incidents is anticipated to fuel the growth of the surgical hemostats market moving forward. Trauma refers to a physical injury or emotional shock caused by a harmful or distressing event, which can impact a person’s body or mind. The increased frequency of trauma cases is primarily attributable to a rise in road traffic accidents, resulting in severe injuries that demand urgent medical intervention. Surgical hemostats are instrumental in controlling bleeding swiftly and effectively during trauma scenarios, minimizing blood loss and stabilizing patients for further medical care. For instance, in 2023, according to the Wisconsin Department of Health Services, a US-based government agency, traumatic injuries caused by assault rose by 3% compared to 2022, increasing from 1,544 cases to 1,584 cases. Therefore, the rising incidence of trauma cases is propelling the growth of the surgical hemostats market.

What Are The Key Segments In The Surgical Hemostats Market?

The surgical hemostats market covered in this report is segmented –

1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types

2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats

3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications

4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge

2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables

3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets

4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives

5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin

6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin

7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

What Key Innovation Trends Are Fueling Advancements In The Surgical Hemostats Market?

Leading companies active in the surgical hemostat market are concentrating on creating enhanced products, leveraging innovative substances such as absorbable oxidized regenerated cellulose (ORC) to improve bleeding management and accelerate wound recovery. Absorbable oxidized regenerated cellulose, a plant-derived biodegradable material, is employed in surgical hemostats to regulate bleeding by establishing a physical barrier and encouraging clot formation at the wound site. For instance, in February 2022, Futura Surgicare Pvt. Ltd., an India-based medical device manufacturing company, introduced Hemostax, an advanced absorbable oxidized regenerated cellulose hemostat designed to effectively manage intraoperative bleeding. This product initiates hemostasis within 1.5 minutes and achieves its complete effect in 2 to 5 minutes. It is fully absorbable within 1 to 2 weeks, negating the requirement for its removal. The product is user-friendly, conforms well to diverse surgical locations, is non-toxic and biocompatible, and demonstrates antibacterial action against drug-resistant bacteria.

Who Are The Prominent Global Companies Shaping The Surgical Hemostats Market?

Major companies operating in the surgical hemostats market are Johnson And Johnson Services Inc., Medtronic plc, Becton Dickinson And Company, Stryker Corporation, Baxter International Inc., Teleflex Corporation, Integra LifeSciences Holdings Corporation., GELITA MEDICAL GmbH, B. Braun Melsungen AG, Advanced Medical Solutions Group plc, Axio Biosolutions Pvt. Ltd., Marine Polymer Technologies Inc, Biom’up USA Inc, Lotus Surgicals Pvt. Ltd, Hemostasis LLC, Biocer Entwicklungs-GmbH, CuraMedical BV, EndoClot Plus Inc, Starch Medical Inc, Tricol Biomedical Inc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

Which Region Is Projected To Lead The Surgical Hemostats Market During The Forecast Period?

North America was the largest region in the surgical hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Surgical Hemostats Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25916&type=smp

Browse Through More Reports Similar to the Global Surgical Hemostats Market 2025, By The Business Research Company

Hemostats Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hemostasis Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hemostasis Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795